Showing posts with label GBI Research. Show all posts
Showing posts with label GBI Research. Show all posts

Wednesday, 30 January 2013

New Research Report: Cumene Global Market to 2020 - Phenol Derivatives from China Continue to Drive Global Demand, Further Increasing Regional Dominance

ResearchMoz.us include new market research report"Cumene Global Market to 2020 - Phenol Derivatives from China Continue to Drive Global Demand, Further Increasing Regional Dominance " to its huge collection of research reports. GBI Researchs report, "Cumene Global Market to 2020 Phenol Derivatives from China Continue to Drive Global Demand, Further Increasing Regional Dominance", is an in-depth report focusing on the demand side of the global cumene industry. The report provides the reader with detailed analysis and forecasts regarding the major economic and market trends affecting global cumene demand in all major regions of the world. It also provides analysis and description of the major drivers and restraints affecting cumene demand in various regions. Global cumene demand is assessed in terms of end-user segments, price and competitive landscape, at both the regional and national level. Overall, the report presents a comprehensive analysis of the global cumene market, covering all major parameters. The report has been compiled using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis carried out by GBI Researchs team of industry experts.

Scope

  • Drivers, restraints and challenges affecting the growth of the cumene market for all major regions: Asia-Pacific, Europe, North America, the Middle East and Africa, and South and Central America
  • Demand and production volume forecasts for the cumene markets of major countries: the US, the UK, Germany, France, Russia, Italy, Poland, Spain, China, Japan, South Korea, India, Thailand, Taiwan, Singapore, Saudi Arabia and Brazil
  • Demand volume forecasts for the major end-user applications, highlighting the trends and volume share analysis for each of these applications in all major countries
  • Pricing forecasts and analysis for the major countries and regions
  • Cumene import and export trends in all the major countries

Reasons to buy


  • Understanding of regional cumene market dynamics through detailed demand and production forecasts, end-use data and competitive landscape analysis
  • Detailed analysis at a country level, providing an insight in order to evaluate opportunities in emerging markets and quantify potential returns on investment
  • Opportunity to obtain a detailed understanding of the factors expected to affect the growth of the cumene market in different regions of the world
  • Identification of the most attractive geographies, product segments and end-user applications, in order to increase business revenue
  • Understanding of the differences of dynamics and pricing between countries, providing an insight into the arbitrage opportunities in the trade across countries
  • Development of custom strategies, based on current and forecast trends in the production and consumption of cumene
  • The opportunity to benefit from advanced insight into each of the major markets, through detailed forecasts for demand, production and end-user analysis
  • Benchmarks for different geographies according to historic and forecast growth of demand, production and the end use of cumene
  • Knowledge regarding the market share held by each of the major producers in the cumene market in different regions of the world

For More Information Kindly Contact: 

Mrs.Sheela AK
Tel:+1-518-618-1030 
Toll Free: 866-997-4948
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Posted by at
Labels: , , ,

Thursday, 24 January 2013

Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share: ResearchMoz.us

GBI Research, the leading business intelligence provider, has released its latest research, Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share, which provides insights into the global statins market until 2018. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Researchs team of industry experts. The report provides an in-depth analysis of the global statins market for dyslipidemia. The report gives insights into the share of generics in the global statins market for the years 2011 and 2018. The report examines the dyslipidemia treatment usage patterns in the US, the top five countries of Europe (The UK, France, Germany, Spain and Italy), and Japan. In addition to the global market landscape for statins, the report also provides details of the geographical distribution of statins sales in the major markets, including the US, the top five countries of Europe, and Japan. The report also includes insights into the statins R&D product pipeline, and explores the competitive landscape, including major players in the statins market. Finally, the report also includes analysis on mergers and acquisitions (M&A) and licensing and co-development deals that have taken place in the statins market.


Statins have dominated the global dyslipidemia therapeutics market for the last few decades. The National Cholesterol Education Program (NECP) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) guidelines have recommended the use of statins as the first choice of pharmacotherapy for the treatment of dyslipidemia. The global statins market, valued at $20.5 billion in 2011, is forecast to decline at a negative Compound Annual Growth Rate (CAGR) of 7.2% over the next seven years, to reach $12.2 billion by 2018. The highly consolidated statins market is expected to become increasingly competitive in the forecast period, with the patent expiries of (atorvastatin calcium), Vytorin (Ezetimibe/simvastatin), Lescol (fluvastatin) and Crestor (rosuvastatin), followed by severe generic erosion. GBI Research estimates that the generic sector in the global statins market will grow significantly in the future and will pose tough competition to new molecules.

Scope

- Data and analysis on the statins market in the leading geographies of the world the US, the UK, Germany, France, Italy, Spain, and Japan. 
- Annualized market data for the statins market from 2004 to 2011, with forecasts to 2018.
- Market data on the geographical landscape and therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population, treatment-seeking population, diagnosis population and prescription population.


- Share of generics in the global statins market.
- Key drivers and restraints that have had a significant impact on the global statins market.
- The competitive landscape of the global statins market, including top companies benchmarking. The key companies studied in this report are Pfizer, AstraZeneca, Merck and Novartis.
- Key M&A activities and licensing agreements that took place in the statins market.

Reasons to buy

- Align their product portfolio to the markets with high growth potential
- Build effective strategies to launch their pipeline products by identifying potential geographies
- Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps
- Develop key strategic initiatives by studying the key strategies of top competitors 
- Devise more tailored country-specific strategies through the understanding of key drivers and barriers and the market potential of each indication for different territories
- Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious

For More Information Kindly Contact: 
Mrs.Sheela AK
Tel:+1-518-618-1030 
Toll Free: 866-997-4948
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Posted by at
Labels: , , ,

Vinyl Acetate Monomer (VAM) Global Market to 2020 - Increased demand in Asia Pacific VA-based EVA Photovoltaic Applications to drive growth: ResearchMoz.us

Vinyl Acetate Monomer (VAM) Global Market to 2020 - Increased demand in Asia Pacific VA-based EVA Photovoltaic Applications to drive growth is an in-depth report from GBI Research, focusing on the demand side of the global VAM industry. The report provides the reader with detailed analysis and forecasts of the economic and market trends affecting global VAM demand in major regions of the world. The report also provides analysis and description of the major drivers and restraints affecting VAM demand in each region. Global VAM demand is assessed in terms of end-user segments, prices, and the competitive landscape, at both the regional and the national level. Overall, the report presents a comprehensive analysis of the global VAM market, covering all major parameters. The report has been compiled using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Researchs team of industry experts.


Scope

- The drivers, restraints and challenges affecting the growth of the Vinyl Acetate Monomer(VAM) market for all major global regions: Asia-Pacific, Europe, North America, the Middle East and Africa, and South and Central America
- Demand and production volume forecasts for the Vinyl Acetate Monomer(VAM) markets of all major countries: the US, Canada, Germany, France, Russia, Italy, Spain, Belgium, Poland, China, Japan, South Korea, India, Thailand, Taiwan, Malaysia, Singapore, Saudi Arabia, Iran, Brazil, Mexico and Argentina
- Demand volume forecasts for the major end-user applications, highlighting trends and volume share analysis for each of these applications in all major countries
- Pricing forecasts and analysis of the major countries and regions
- Capacity share analysis of the key producers in all the major countries
- The acetic acid import and export trends in all major countries
- The acetic acid installed capacity for 2010-2016 in all major regions


Reasons to buy

- Understand regional market dynamics through detailed demand and production forecasts, end-use data and competitive landscape analysis 
- Understand the differing pricing dynamics between various regions and countries
- Understand the drivers and resistors shaping your current and potential future markets
- Identify key growth markets for your products from validated, country-level data and analysis
- Identify emerging markets and investment opportunities in both general and niche markets
- Evaluate opportunities in emerging markets to quantify potential returns on investment
- Develop custom strategies armed with validated historic and forecast data, combined with detailed growth opportunities analysis
- Make better-informed decisions based on insights and in-depth analysis of market landscapes and the factors shaping them
- Benchmark different geographies by the historic and forecast growth of demand, production and end-use of acetic acid
- Refine business strategies with a fuller understanding of the trends and developments shaping your markets
- Gain knowledge regarding the market share of each of the major producers in the market in different regions of the world

For More Information Kindly Contact: 

Mrs.Sheela AK
Tel:+1-518-618-1030 
Toll Free: 866-997-4948
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Posted by at
Labels: , , ,

Cumene Global Market to 2020 - Phenol Derivatives from China Continue to Drive Global Demand, Further Increasing Regional Dominance: ResearchMoz.us


ResearchMoz.us provides new market research report on " Cumene Global Market to 2020 - Phenol Derivatives from China Continue to Drive Global Demand, Further Increasing Regional Dominance" . GBI Research's report, "Cumene Global Market to 2020 - Phenol Derivatives from China Continue to Drive Global Demand, Further Increasing Regional Dominance", is an in-depth report focusing on the demand side of the global cumene industry. The report provides the reader with detailed analysis and forecasts regarding the major economic and market trends affecting global cumene demand in all major regions of the world. It also provides analysis and description of the major drivers and restraints affecting cumene demand in various regions. Global cumene demand is assessed in terms of end-user segments, price and competitive landscape, at both the regional and national level. Overall, the report presents a comprehensive analysis of the global cumene market, covering all major parameters. The report has been compiled using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis carried out by GBI Researchs team of industry experts.


Scope

- Drivers, restraints and challenges affecting the growth of the cumene market for all major regions: Asia-Pacific, Europe, North America, the Middle East and Africa, and South and Central America
- Demand and production volume forecasts for the cumene markets of major countries: the US, the UK, Germany, France, Russia, Italy, Poland, Spain, China, Japan, South Korea, India, Thailand, Taiwan, Singapore, Saudi Arabia and Brazil
- Demand volume forecasts for the major end-user applications, highlighting the trends and volume share analysis for each of these applications in all major countries
- Pricing forecasts and analysis for the major countries and regions
- Cumene import and export trends in all the major countries


Reasons to buy

- Understanding of regional cumene market dynamics through detailed demand and production forecasts, end-use data and competitive landscape analysis
- Detailed analysis at a country level, providing an insight in order to evaluate opportunities in emerging markets and quantify potential returns on investment
- Opportunity to obtain a detailed understanding of the factors expected to affect the growth of the cumene market in different regions of the world
- Identification of the most attractive geographies, product segments and end-user applications, in order to increase business revenue
- Understanding of the differences of dynamics and pricing between countries, providing an insight into the arbitrage opportunities in the trade across countries
- Development of custom strategies, based on current and forecast trends in the production and consumption of cumene
- The opportunity to benefit from advanced insight into each of the major markets, through detailed forecasts for demand, production and end-user analysis
- Benchmarks for different geographies according to historic and forecast growth of demand, production and the end use of cumene
- Knowledge regarding the market share held by each of the major producers in the cumene market in different regions of the world

For More Information Kindly Contact: 

Mrs.Sheela AK
Tel:+1-518-618-1030 
Toll Free: 866-997-4948
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Posted by at
Labels: , , ,

MarketResearchReports.biz Publishes Dental Implants Market to 2018


GBI Research's report, "Dental Implants Market to 2018 - Technical Advancements and Procedure Efficiency are Resulting in the Increased Preference for Dental Implants over Traditional Dental Devices" provides key data, information and analysis for the global dental implants market. It examines the market and competitive landscape and trends for the titanium dental implants and zirconium dental implants segments and provides comprehensive information on key trends and dynamics. The report also looks at the pipeline products in each segment and gives details of important M&A activity.

To Buy The Copy Of This Report visit:  http://www.marketresearchreports.biz/analysis-details/dental-implants-market-to-2018-technical-advancements-and-procedure-efficiency-are-resulting-in-the-increased-preference-for-dental-implants-over-traditional-dental-devices



It has been built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

- Key market geographies of the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil
- Market size data for the titanium dental implants and zirconium dental implants segments
- Annualized market revenue data forecast from 2011 to 2018 and company share data for 2011
- Qualitative analysis of key trends in the dental implants market
- Information on the leading players and technologies in the market


To Read The Complete Report with TOC Kindly Visit: http://www.marketresearchreports.biz/analysis/160072


Reasons to buy

- Develop business strategies by understanding the trends and developments driving the global dental implants market
- Design and develop your product development, marketing and sales strategies
- Exploit M&A opportunities by identifying the market players with the most innovative pipelines
- Develop market-entry and market-expansion strategies
- Identify the key players best positioned to take advantage of the emerging market opportunities
- Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return
- Identify, understand and capitalize on the next big thing in the dental implants market landscape
- Make more informed business decisions using the reports insightful and in-depth analysis of the global dental implants market and the factors shaping it

For More Information Kindly Contact:
Hemendra Parmar
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
sales@marketResearchReports.biz
website: http://www.marketresearchreports.biz/
Blog: http://mrrbiz.blogspot.pt/
Posted by at
Labels:

MarketResearchReports.biz Publishes Inherited Orphan Blood Disorders Therapeutics Market to 2019

GBI Research, the leading business intelligence provider, has released its latest research, Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need. The report provides insights into the up-and-coming trends of a portion of the inherited orphan blood disorder pharmaceutical market by examining sickle cell anemia, thalassemia and Hereditary Angioedema (HAE) in seven major markets: the US, the top five European countries (France, Germany, Italy, Spain and the UK) and Japan. The report includes market forecasts to 2019, detailed pipeline analysis, in-depth profiling of major products and details of recent industry deals.

To Buy The Copy Of This Report visit: http://www.marketresearchreports.biz/analysis-details/inherited-orphan-blood-disorders-therapeutics-market-to-2019-breakthrough-drugs-remain-elusive-against-backdrop-of-high-unmet-need


The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Researchs team of industry experts.

The sickle cell anemia market will be the fastest growing of the three markets during the forecast period with a Compound Annual Growth Rate (CAGR) of 9% seeing it reach $70m in 2019. The thalassemia market will grow at a lower CAGR of 7% to reach $59m in 2019. HAE represents the largest but slowest growing market, expected to reach $1.89 billion by 2019 at a CAGR of 3%.

Scope

- Current and future treatment trends for three rare diseases
- Market forecasts for three rare diseases across seven major markets
- Analysis of the developmental pipelines for three rare diseases
- Information on recent industry deals


To Read The Complete Report with TOC Kindly Visit: http://www.marketresearchreports.biz/analysis/160071


Reasons to buy

- Understand how the inherited orphan blood diseases market has developed and is continuing to develop within the featured markets
- Predict which products are likely to be most successful in the future
- Gain an understanding of the possible market available for specific products


For More Information Kindly Contact:
Hemendra Parmar
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
sales@marketResearchReports.biz
website: http://www.marketresearchreports.biz/
Blog: http://mrrbiz.blogspot.hk/
Posted by at
Labels:

MarketResearchReports.biz Publishes Diabetes Therapeutics Market in India to 2018


GBI Research, the leading business intelligence provider, has released its latest research Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive Growth, which provides insights into the India anti-diabetes market until 2018. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts. Insights into the diabetes epidemiology, cost of therapy, research and development pipeline and the promising molecules which are anticipated to be launched by 2018 are discussed in the report. The report provides an in-depth analysis type 1 and type 2 diabetes. The report provides an in-depth analysis on oral anti-diabetics agents, insulin products and drivers and barriers that could significantly impact the overall anti-diabetes market during the forecast period. Additionally, it explores the competitive landscape, including benchmarking the top companies in the market and the key issues and trends that are likely to have an impact on the Indian diabetes market during the forecast period. Finally, a key trend analysis for mergers and acquisitions and licensing agreements involving diabetes therapies is also discussed in the report.

To Buy The Copy Of This Report visit: http://www.marketresearchreports.biz/analysis-details/diabetes-therapeutics-market-in-india-to-2018-rapid-uptake-of-dpp-iv-inhibitors-glp-1-agonists-and-expanding-insulin-segment-to-drive-growth


Scope

- Data and analysis on the Indian diabetes therapeutics market
- Annualized market data for the diabetes therapeutics market from 2004 to 2011, with forecasts to 2018 for type 1 and type 2 diabetes.
- Epidemiological data on type 1 and type 2 diabetes along with market size, annual cost of therapy, unmet needs and economic burden of diabetes.
- Key drivers and restraints that have had a significant impact on the market.
- Major trends and issues which are likely to have a significant impact on overall diabetes therapeutics market in India
- Competitive landscape of the diabetes therapeutics market including top companies benchmarking. The key companies studied in this report are Novo Nordisk, Sanofi, Novartis, Eli Lilly, Merck, Abbott, USV, Sun Pharma, Biocon and Wockhardt.
- Key M&A activities and licensing agreements, major deals that took place in last four years in Indian diabetes therapeutics market.

To Read The Complete Report with TOC Kindly Visit: http://www.marketresearchreports.biz/analysis/160070



Reasons to buy

- Align their product portfolio to the markets with high growth potential.
- Build effective strategies to launch their pipeline products by identifying potential geographies.
- Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
- Develop key strategic initiatives by studying the key strategies of top competitors.
- Devise a more tailored country strategy through the understanding of key drivers and barriers and market potential.
- Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.

For More Information Kindly Contact:
Hemendra Parmar
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
sales@marketResearchReports.biz
website: http://www.marketresearchreports.biz/
Blog: http://mrrbiz.blogspot.gr/
Posted by at
Labels:
Subscribe to: Posts (Atom)